10x Genomics TXG
NASDAQ TXG
$69.89 +0.03 (+0.04%)
At close: Oct 19, 2026 · 4:00 PM EDT

10x Genomics (TXG) Debt Ratio (2018 - 2019)

Updated

10x Genomics' (TXG) Debt Ratio was 0.05 for Q4 2019, down 79.5% from 0.24 a year earlier and down 5.4% from the prior quarter.

Analysis

10x Genomics (TXG) Debt Ratio (2018 - 2019) Analysis & Trends

  • By year, Debt Ratio came in at 0.24 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn 0.38
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn 0.30
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn 0.29
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn -
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn 0.30
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn 0.31
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn 0.28
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn 0.33
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn 0.04
10 10x Genomics 9.07 Bn 8.87 Bn 112.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 0.05
Sep 30, 2019 0.05
Dec 31, 2018 0.24
API Access

10x Genomics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TXG&period=max&api_key=YOUR_API_KEY